 Changes haemostasis combined contraceptive pill implications major surgery OBJECTIVE changes haemostasis months combined contraceptive pill DESIGN Prospective study SETTING centre London SUBJECTS women months use combined oral contraceptives micrograms progestogens desogestrel gestodene MAIN OUTCOME MEASURES AND RESULTS Blood samples months oral contraceptive use weeks pill months oral contraceptive plasma concentration factor fibrinogen antithrombin III Between weeks pill rebound phenomenon plasma concentrations antithrombin III mean change baseline weeks IU/l weeks IU/l decreasing g/l change weeks g/l weeks Factor concentrations values weeks different pill CONCLUSION combined pill weeks major surgery risk postoperative thrombosis prothrombotic haemostatic changes use